Ashby, Kristin, Wei Zhuang, Andres González-Jimenez, Ismael Alvarez-Alvarez, M Isabel Lucena, Raúl J. Andrade, Guruprasad P. Aithal, Ayako Suzuki, and Minjun Chen. “Elevated bilirubin, alkaline phosphatase at onset, and drug metabolism are associated with prolonged recovery from DILI.” J Hepatol 75, no. 2 (August 2021): 333–41. https://doi.org/10.1016/j.jhep.2021.03.021.
Sarkar, Monika A., Ayako Suzuki, Manal F. Abdelmalek, Katherine P. Yates, Laura A. Wilson, Nathan M. Bass, Ryan Gill, Marcelle Cedars, Norah Terrault, and Norah NASH Clinical Research Network. “Testosterone is Associated With Nonalcoholic Steatohepatitis and Fibrosis in Premenopausal Women With NAFLD.” Clin Gastroenterol Hepatol 19, no. 6 (June 2021): 1267-1274.e1. https://doi.org/10.1016/j.cgh.2020.09.045.
Gonzalez-Jimenez, Andres, Ayako Suzuki, Minjun Chen, Kristin Ashby, Ismael Alvarez-Alvarez, Raul J. Andrade, and M Isabel Lucena. “Drug properties and host factors contribute to biochemical presentation of drug-induced liver injury: a prediction model from a machine learning approach.” Arch Toxicol 95, no. 5 (May 2021): 1793–1803. https://doi.org/10.1007/s00204-021-03013-3.
Wegermann, Kara, Ayako Suzuki, Alisha M. Mavis, Manal F. Abdelmalek, Anna Mae Diehl, and Cynthia A. Moylan. “REPLY.” Hepatology 73, no. 4 (April 2021): 1625. https://doi.org/10.1002/hep.31593.
Wegermann, Kara, Melanie E. Garrett, Jiayin Zheng, Andrea Coviello, Cynthia A. Moylan, Manal F. Abdelmalek, Shein-Chung Chow, et al. “Sex and Menopause Modify the Effect of Single Nucleotide Polymorphism Genotypes on Fibrosis in NAFLD.” Hepatol Commun 5, no. 4 (April 2021): 598–607. https://doi.org/10.1002/hep4.1668.
Wegermann, Kara, Ayako Suzuki, Alisha M. Mavis, Manal F. Abdelmalek, Anna Mae Diehl, and Cynthia A. Moylan. “Tackling Nonalcoholic Fatty Liver Disease: Three Targeted Populations.” Hepatology 73, no. 3 (March 2021): 1199–1206. https://doi.org/10.1002/hep.31533.
Sarkar, Monika, Katherine Yates, Ayako Suzuki, Joel Lavine, Ryan Gill, Toni Ziegler, Norah Terrault, and Sandeep Dhindsa. “Low Testosterone Is Associated With Nonalcoholic Steatohepatitis and Fibrosis Severity in Men.” Clin Gastroenterol Hepatol 19, no. 2 (February 2021): 400-402.e2. https://doi.org/10.1016/j.cgh.2019.11.053.
Beachler, Daniel C., Cynthia de Luise, Aziza Jamal-Allial, Ruihua Yin, Devon H. Taylor, Ayako Suzuki, James H. Lewis, James W. Freston, and Stephan Lanes. “Real-world safety of palbociclib in breast cancer patients in the United States: a new user cohort study.” Bmc Cancer 21, no. 1 (January 25, 2021): 97. https://doi.org/10.1186/s12885-021-07790-z.
Tripathi, Madhulika, Bnjesh Kumar Singh, Jin Zhou, Keziah Tikno, Anissa Anindya Widjaja, Reddemma Sandireddy, Ayako Suzuki, et al. “HYPERHOMOCYSTEINEMIA IS A MARKER AND MEDIATOR OF NASH: DISCOVERY OF A NOVEL VITAMIN THERAPY (B12 AND FOLATE) FOR NASH.” In Hepatology, 72:52A-52A, 2020.
Sarkar, Monika, Ayako Suzuki, Manal F. Abdelmalek, Nathan M. Bass, Laura Wilson, Katherine Yates, Marcelle Cedars, Ryan Gill, and Norah Terrault. “TESTOSTERONE IS A KEY RISK FACTOR FOR NONALCOHOLIC STEATOHEPATITIS (NASH) AND FIBROSIS IN YOUNG PRE-MENOPAUSAL WOMEN WITH FATTY LIVER.” In Hepatology, 72:996–97, 2020.